| 000 | 01508 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511152410.0 | ||
| 264 | 0 | _c19760423 | |
| 008 | 197604s 0 0 eng d | ||
| 022 | _a0011-393X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCockcroft, D W | |
| 245 | 0 | 0 |
_aCarbuterol: a double-blind clinical trial comparing carbuterol and salbutamol. _h[electronic resource] |
| 260 |
_bCurrent therapeutic research, clinical and experimental _cFeb 1976 |
||
| 300 |
_a170-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAirway Obstruction _xphysiopathology |
| 650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xphysiopathology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBronchitis _xphysiopathology |
| 650 | 0 | 4 | _aBronchodilator Agents |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEthanolamines _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximal Midexpiratory Flow Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPeak Expiratory Flow Rate |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aVital Capacity |
| 700 | 1 | _aDonevan, R E | |
| 700 | 1 | _aCopland, G M | |
| 773 | 0 |
_tCurrent therapeutic research, clinical and experimental _gvol. 19 _gno. 2 _gp. 170-9 |
|
| 999 |
_c822530 _d822530 |
||